KEGG   Carlito syrichta (Philippine tarsier): 103266974
Entry
103266974         CDS       T07836                                 
Symbol
CDKN1A
Name
(RefSeq) cyclin-dependent kinase inhibitor 1
  KO
K06625  cyclin-dependent kinase inhibitor 1A
Organism
csyr  Carlito syrichta (Philippine tarsier)
Pathway
csyr01522  Endocrine resistance
csyr01524  Platinum drug resistance
csyr04012  ErbB signaling pathway
csyr04066  HIF-1 signaling pathway
csyr04068  FoxO signaling pathway
csyr04110  Cell cycle
csyr04115  p53 signaling pathway
csyr04151  PI3K-Akt signaling pathway
csyr04218  Cellular senescence
csyr04630  JAK-STAT signaling pathway
csyr04921  Oxytocin signaling pathway
csyr04928  Parathyroid hormone synthesis, secretion and action
csyr04934  Cushing syndrome
csyr05160  Hepatitis C
csyr05161  Hepatitis B
csyr05163  Human cytomegalovirus infection
csyr05165  Human papillomavirus infection
csyr05166  Human T-cell leukemia virus 1 infection
csyr05167  Kaposi sarcoma-associated herpesvirus infection
csyr05169  Epstein-Barr virus infection
csyr05200  Pathways in cancer
csyr05202  Transcriptional misregulation in cancer
csyr05203  Viral carcinogenesis
csyr05205  Proteoglycans in cancer
csyr05206  MicroRNAs in cancer
csyr05210  Colorectal cancer
csyr05211  Renal cell carcinoma
csyr05212  Pancreatic cancer
csyr05213  Endometrial cancer
csyr05214  Glioma
csyr05215  Prostate cancer
csyr05216  Thyroid cancer
csyr05217  Basal cell carcinoma
csyr05218  Melanoma
csyr05219  Bladder cancer
csyr05220  Chronic myeloid leukemia
csyr05222  Small cell lung cancer
csyr05223  Non-small cell lung cancer
csyr05224  Breast cancer
csyr05225  Hepatocellular carcinoma
csyr05226  Gastric cancer
Brite
KEGG Orthology (KO) [BR:csyr00001]
 09130 Environmental Information Processing
  09132 Signal transduction
   04012 ErbB signaling pathway
    103266974 (CDKN1A)
   04630 JAK-STAT signaling pathway
    103266974 (CDKN1A)
   04066 HIF-1 signaling pathway
    103266974 (CDKN1A)
   04068 FoxO signaling pathway
    103266974 (CDKN1A)
   04151 PI3K-Akt signaling pathway
    103266974 (CDKN1A)
 09140 Cellular Processes
  09143 Cell growth and death
   04110 Cell cycle
    103266974 (CDKN1A)
   04115 p53 signaling pathway
    103266974 (CDKN1A)
   04218 Cellular senescence
    103266974 (CDKN1A)
 09150 Organismal Systems
  09152 Endocrine system
   04921 Oxytocin signaling pathway
    103266974 (CDKN1A)
   04928 Parathyroid hormone synthesis, secretion and action
    103266974 (CDKN1A)
 09160 Human Diseases
  09161 Cancer: overview
   05200 Pathways in cancer
    103266974 (CDKN1A)
   05202 Transcriptional misregulation in cancer
    103266974 (CDKN1A)
   05206 MicroRNAs in cancer
    103266974 (CDKN1A)
   05205 Proteoglycans in cancer
    103266974 (CDKN1A)
   05203 Viral carcinogenesis
    103266974 (CDKN1A)
  09162 Cancer: specific types
   05210 Colorectal cancer
    103266974 (CDKN1A)
   05212 Pancreatic cancer
    103266974 (CDKN1A)
   05225 Hepatocellular carcinoma
    103266974 (CDKN1A)
   05226 Gastric cancer
    103266974 (CDKN1A)
   05214 Glioma
    103266974 (CDKN1A)
   05216 Thyroid cancer
    103266974 (CDKN1A)
   05220 Chronic myeloid leukemia
    103266974 (CDKN1A)
   05217 Basal cell carcinoma
    103266974 (CDKN1A)
   05218 Melanoma
    103266974 (CDKN1A)
   05211 Renal cell carcinoma
    103266974 (CDKN1A)
   05219 Bladder cancer
    103266974 (CDKN1A)
   05215 Prostate cancer
    103266974 (CDKN1A)
   05213 Endometrial cancer
    103266974 (CDKN1A)
   05224 Breast cancer
    103266974 (CDKN1A)
   05222 Small cell lung cancer
    103266974 (CDKN1A)
   05223 Non-small cell lung cancer
    103266974 (CDKN1A)
  09172 Infectious disease: viral
   05166 Human T-cell leukemia virus 1 infection
    103266974 (CDKN1A)
   05161 Hepatitis B
    103266974 (CDKN1A)
   05160 Hepatitis C
    103266974 (CDKN1A)
   05163 Human cytomegalovirus infection
    103266974 (CDKN1A)
   05167 Kaposi sarcoma-associated herpesvirus infection
    103266974 (CDKN1A)
   05169 Epstein-Barr virus infection
    103266974 (CDKN1A)
   05165 Human papillomavirus infection
    103266974 (CDKN1A)
  09167 Endocrine and metabolic disease
   04934 Cushing syndrome
    103266974 (CDKN1A)
  09176 Drug resistance: antineoplastic
   01524 Platinum drug resistance
    103266974 (CDKN1A)
   01522 Endocrine resistance
    103266974 (CDKN1A)
SSDB
Motif
Pfam: CDI
Other DBs
NCBI-GeneID: 103266974
NCBI-ProteinID: XP_008062774
Ensembl: ENSTSYG00000026973
UniProt: A0A1U7TS19
LinkDB
Position
Unknown
AA seq 164 aa
MSEQAGDARQIPCSSKVCRRLFGPVDSEQLRRDCDALMAGCVQEARERWNFDFITETPLE
GDFAWERVWGLSLPKLYLPTGPRGCRDDLGGGKRPGASPALLQGTAQEDHVDLSLSCTLV
PHSGERSEGSPGGPGASQGRKRRQTSLTDFYHSKRRLIFSKRKP
NT seq 495 nt   +upstreamnt  +downstreamnt
atgtcggagcaggctggggacgcccgtcagattccctgcagcagcaaggtgtgccgccgc
ctctttggcccggtggacagcgagcaactgcgccgtgactgtgacgcactgatggccggc
tgcgtgcaggaggcccgcgagcgatggaacttcgacttcatcaccgagacgccgctggag
ggcgatttcgcctgggagcgtgtgtggggcctcagcctgcccaagctctacctgcccacg
gggccccgggggtgccgggatgacttgggagggggcaagcggcctggcgcctcacctgcc
ctgctgcaggggacagcacaggaagaccacgtggacctgtcgctgtcctgcacccttgtg
cctcactcaggggagaggtccgaggggtccccaggtgggcctggagcctctcagggacgg
aagcggcggcagaccagcctgacagatttctaccactccaagcgccgactgatcttctcc
aagaggaagccctaa

DBGET integrated database retrieval system